Today in News History
On July 12, several notable moments in the history of News stand out. In 965, Meng Chang, emperor of Later Shu (born 919) passed away. In 1488, Joseon Dynasty official Choe Bu returned to Korea after months of shipwrecked travel in China. In 1933, Victor Poor, American engineer, developed the Datapoint 2200 (died 2012) was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 1938, Eiko Ishioka, Japanese art director and graphic designer (died 2012) was born. In 2001, Space Shuttle program: Space Shuttle Atlantis is launched on mission STS-104, carrying the Quest Joint Airlock to the International Space Station. In 2006, The 2006 Lebanon War begins. In 2015, Cheng Siwei, Chinese engineer, economist, and politician (born 1935) passed away. In 2020, Kelly Preston, American actress and model (born 1962) passed away. In 2024, Evan Wright, American writer (born 1964) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Korean biotech eyes deals, partnerships at BIO 2026
A flock of Korean biopharmaceutical and biotechnology companies are heading to San Diego this week with their eyes on expanding global partnerships and securing contracts at the BIO International Convention, one of the world’s largest exhibitions in the biotechnology industry. Samsung Biologics, which will take part in the annual event for the 14th consecutive year, said it will once again set up a large booth with a floor space of 140 square meters at the center stage. The Korean contract devel
Narrative Intelligence Brief
This article was published by The korea Herald News, a source frequently categorized with a center bias based in South Korea. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The korea Herald News, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from The korea Herald News
July 12, 2026
Murder attempt victim protests abolishing prosecution's right to additional investigation
July 12, 2026
How the absence of Iran's new supreme leader is becoming a liability for the Islamic Republic
July 12, 2026
The next drug lab is in orbit
July 12, 2026
Late-night fried chicken? Tourists are ordering like locals
July 12, 2026
KB chair puts AI at center of next growth phase
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 33%
Center 33%
Right 17%
The korea Herald News
· Jun 23, 2026
[Bio USA] Korean biotechs bolster AstraZeneca partnership
SAN DIEGO — Korean biotechnology firms have advanced their partnerships with AstraZeneca, bolstering efforts toward open innovation and technological cooperation for eventual entrance into the global market. Under the name Project NOVA, the Korea Health Industry Development Institute on Monday held AstraZeneca partnering sessions for 13 Korean companies on the sidelines of the BIO International Convention taking place this week in San Diego. “We have a very good track record of doing excellent p
The Motley Fool
· Jun 28, 2026
Will Amazon, Taiwan Semiconductor, SpaceX, or Broadcom Be the Next $3 Trillion Company?
This cohort is linked by one common theme.
Ars Technica
· Jun 25, 2026
New effort will get genome sequences for entire Endangered Species list
Colossal Biosciences will be biobanking tissues from all of them as well.
The Hindu BusinessLine
· Jun 23, 2026
CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea's Hub for Pharma, Biopharma, and Health Innovation
CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea's Hub for Pharma, Biopharma, and Health Innovation
Utusan Malaysia
· Jul 11, 2026
Teknologi sel stem Switzerland perkukuh inovasi anti-penuaan tempatan
PUTRAJAYA: Kerjasama strategik antara syarikat bioteknologi Switzerland, Mibelle Biochemistry dan NovaBio CellTech Sdn. Bhd. dijangka menjadi pemangkin kepada pembangunan produk kesihatan berasaskan teknologi sel stem tumbuhan di Malaysia, sekali gus memperluaskan amalan penjagaan kesihatan secara pencegahan serta konsep regenerative longevity atau kelanjutan usia yang sihat. Pengasas Mibelle Biochemistry, Dr. Fred Zulli berkata, syarikatnya menjadi perintis ... Read more The post Teknologi sel stem Switzerland perkukuh inovasi anti-penuaan tempatan appeared first on Utusan Malaysia.
The Next Web
· Jul 6, 2026
Novartis buys UK biotech Myricx for up to $1.5bn to chase a new cancer-drug class
Novartis has agreed to buy Myricx Bio, a small British oncology company, for up to 1.5bn, adding an early-stage but potentially significant technology to a cancer pipeline the industry keeps racing to expand. The Swiss group will pay 1.1bn upfront, with up to 400m more tied to milestones, in a deal that fits the pattern [] This story continues at The Next Web
Topics:
Related coverage for "Korean biotech eyes deals, partnerships at BIO 2026": The korea Herald News — [Bio USA] Korean biotechs bolster AstraZeneca partnership. The Motley Fool — Will Amazon, Taiwan Semiconductor, SpaceX, or Broadcom Be the Next $3 Trillion Company?. Ars Technica — New effort will get genome sequences for entire Endangered Species list. The Hindu BusinessLine — CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea's Hub for Pharma, Biopharma, and Health Innovation. Utusan Malaysia — Teknologi sel stem Switzerland perkukuh inovasi anti-penuaan tempatan. The Next Web — Novartis buys UK biotech Myricx for up to $1.5bn to chase a new cancer-drug class